CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Fidaxomicin

Last Updated: July 11, 2012
Result type: Reports
Project Number: SR0285
Product Line: Common Drug Review

Generic Name: Fidaxomicin

Brand Name: Dificid

Manufacturer: Optimer Pharmaceuticals Canada, Inc.

Indications: Clostridium difficile infection

Submission Type: New

Project Status: Complete

Date Recommendation Issued: December 19, 2012

Recommendation Type: Do not list at the submitted price